GUTS
Fractyl Health, Inc. Common StockNASDAQHealthcare$0.46-1.89%ClosedMarket Cap: $32.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.66
P/S
0.00
EV/EBITDA
-0.11
DCF Value
$0.24
FCF Yield
-275.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
10146.0%
ROA
-116.1%
ROIC
-89.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-23.3M | $-43.7M | $-0.58 | — |
| FY 2025 | $0.00 | -Infinity% | $-96.8M | $-141.0M | $-1.86 | — |
| Q3 2025 | $0.00 | -Infinity% | $-22.7M | $-45.6M | $-0.71 | — |
| Q2 2025 | $0.00 | NaN% | $-26.1M | $-27.9M | $-0.57 | — |
| Q1 2025 | $0.00 | NaN% | $-24.8M | $-23.7M | $-0.49 | — |
| Q4 2024 | $3.0K | 100.0% | $-25.2M | $-25.0M | $-0.51 | — |
| FY 2024 | $93.0K | 46.2% | $-93.5M | $-68.7M | $-1.62 | — |
| Q3 2024 | $14.0K | 50.0% | $-23.8M | $-23.2M | $-0.48 | — |
| Q2 2024 | $43.0K | 44.2% | $-23.0M | $-17.2M | $-0.36 | — |
| Q1 2024 | $33.0K | 42.4% | $-21.5M | $-3.3M | $-0.11 | — |
| Q4 2023 | $7.0K | 71.4% | $-13.0M | $-19.2M | $-0.40 | — |
| FY 2023 | $120.0K | 35.8% | $-50.8M | $-77.1M | $-1.98 | — |